Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association

Gary Gintant, Paul Burridge, Lior Gepstein, Sian Harding, Todd Herron, Charles Hong, José Jalife, Joseph C. Wu

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations

Fingerprint Dive into the research topics of 'Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association'. Together they form a unique fingerprint.

Medicine & Life Sciences